Dr. Wasim Mouazzen, MD

Dr. Mouazzen practices at Emanate Health Foothill Presbyterian Hospital - Mammography in Glendora, California.

Dr. Mouazzen's NPI, 1326542010, was assigned on March 19, 2018. Dr. Mouazzen graduated from Ross University School of Medicine in 2015. Dr. Mouazzen holds California license A173406.

Dr. Mouazzen's primary practice is Emanate Health Foothill Presbyterian Hospital - Mammography, at 250 S Grand Ave., Glendora, CA 91741. The practice phone is (626) 857-3118.

Dr. Mouazzen's primary practice is Emanate Health Foothill Presbyterian Hospital - Mammography in Glendora, California. Dr. Mouazzen is also affiliated with Emanate Health Foothill Presbyterian Hospital. The medical group on file is Vituity. Dmand AI also links Dr. Mouazzen to 3 more hospitals, 5 medical groups, 1 physician office, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mouazzen practices, 9 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Mouazzen's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Mouazzen is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mouazzen is licensed in California.

Dmand AI lists acute diabetes, acute respiratory failure, cardiac arrhythmia, cellulitis, congestive heart failure, electrolyte disorders, gastrointestinal bleeding and gastrointestinal inflammation among the conditions Dr. Mouazzen treats.

CMS data shows 996 Medicare services from Dr. Mouazzen across 6 procedure codes in 2024, for 340 Medicare patients. Medicare paid $93,063 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 340 Medicare patients who saw Dr. Mouazzen in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mouazzen's median patient age at 66, with 53% women.

In 2024, Dr. Mouazzen wrote 322 Medicare Part D claims for 145 patients. 87% of them were for generic drugs. CMS names the drug for 124 of them, across 9 drugs with 11 or more claims each, at $12,376 in total drug cost. In 2023, CMS named 37 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Mouazzen for performance year 2024, reported as part of a group. Dr. Mouazzen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Mouazzen from 4 drug and device companies from 2020 to 2021. Food and beverage make up the largest share, 100% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $27.

Dr. Mouazzen graduated from Ross University School of Medicine in 2015.

Dr. Mouazzen is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.